The role of MCT1 in tumor progression and targeted therapy: a comprehensive review
Overexpression of monocarboxylate transporter 1 (MCT1) in tumor cells is often associated with poor prognosis. The established mechanisms through which MCT1 and its mediated lactate transport drive tumor progression are manifold. The classical mechanisms include fostering metabolic symbiosis among t...
Saved in:
| Main Authors: | Zheng Xu, Xuemei Wang, Hongjing Cheng, Jiuling Li, Xin Zhang, Xueju Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1610466/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
by: Jordina Rincon-Torroella, et al.
Published: (2025-05-01) -
Circulating Endocannabinoids in Canine Cutaneous Mast Cell Tumor
by: Valentina Rinaldi, et al.
Published: (2024-10-01) -
Catalytically inactive carbonic anhydrase‐related proteins enhance transport of lactate by MCT1
by: Ashok Aspatwar, et al.
Published: (2019-07-01) -
A Very Thin MCT Film in HDVIP Achieves High Absorption
by: Lingwei Jiang, et al.
Published: (2025-06-01) -
Rare cause of ketolysis: Monocarboxylate transporter 1 deficiency
by: Ayşe Ergül Bozacı, et al.
Published: (2022-08-01)